 | Is Sorrento Therapeutics (NASDAQ:SRNE) More Than Just A COVID-19 Play
marketbeat.com - October 19 at 9:18 AM |
| Sorrento Therapeutics (NASDAQ:SRNE) Quietly Moves Higher On COVID News
marketbeat.com - October 13 at 3:34 PM |
 | Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies
finance.yahoo.com - March 2 at 9:43 AM |
 | Sorrento Therapeutics (NASDAQ:SRNE) Trading 6% Higher
americanbankingnews.com - March 1 at 9:00 PM |
| Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid Syndrome
finance.yahoo.com - March 1 at 1:23 PM |
 | SORRENTO INVESTIGATION INITIATED by Former...
benzinga.com - February 27 at 2:21 AM |
| SORRENTO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
finance.yahoo.com - February 27 at 2:21 AM |
 | Busy Week for Earnings to Start March
baystreet.ca - February 26 at 4:20 PM |
|
| Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 7.7%
americanbankingnews.com - February 25 at 8:58 PM |
 | Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
msn.com - February 22 at 1:41 PM |
| Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 8.4%
americanbankingnews.com - February 18 at 8:34 PM |
 | The Case For Sorrento Therapeutics: Its Antibody Library
seekingalpha.com - February 18 at 5:15 AM |
 | Sorrento (SRNE) to Report Q4 Earnings: What's in the Cards?
nasdaq.com - February 17 at 12:30 PM |
| Sorrento Therapeutics Reports Promising Data From an Uncontrolled Clinical Trial
finance.yahoo.com - February 12 at 2:01 PM |
| Comparing Sorrento Therapeutics (NASDAQ:SRNE) and BiondVax Pharmaceuticals (NASDAQ:BVXV)
americanbankingnews.com - February 12 at 12:32 AM |
| How Risky Are These Heavily Shorted COVID Stocks?
finance.yahoo.com - February 11 at 8:02 AM |
| Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Down 5.1%
americanbankingnews.com - February 10 at 8:26 PM |
| Sorrento: New Platform Further Underscores the Bull Case
finance.yahoo.com - February 9 at 6:50 PM |
| Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer
finance.yahoo.com - February 9 at 1:50 PM |
| Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic
finance.yahoo.com - February 8 at 8:00 PM |
| Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Up 18.3%
americanbankingnews.com - February 8 at 7:12 PM |
| Whether Sorrento Therapeutics Could Benefit From A Short Squeeze
seekingalpha.com - February 5 at 12:47 PM |
| March 26th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - February 4 at 3:12 PM |
| Sorrento: Breaking Down B. Riley’s New Bullish Call
nasdaq.com - February 1 at 10:47 PM |
| Update to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem Cells
finance.yahoo.com - January 31 at 7:43 PM |
| Sorrento Therapeutics Stock Could More Than Double, Says Analyst
finance.yahoo.com - January 30 at 1:09 PM |
| First Week of SRNE February 19th Options Trading
nasdaq.com - January 29 at 2:35 PM |
 | Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC(TM) for Treatment of ICU COVID-19 Patients
marketwatch.com - January 27 at 9:25 AM |
|
| Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
finance.yahoo.com - January 26 at 10:24 PM |
| Sorrento Stock Has Multiple Catalysts in Play; Analyst Says ‘Buy’
finance.yahoo.com - January 25 at 8:17 PM |
| Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji Presents at B. Riley Virtual Oncology Conference (Transcript)
seekingalpha.com - January 22 at 6:07 PM |
 | What’s Next For Sorrento After A 35% Move In Last 5 Trading Days?
forbes.com - January 22 at 8:06 AM |
| March 5th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - January 21 at 2:32 PM |
| Why Sorrento Therapeutics's Stock is Up During Today's Session
msn.com - January 20 at 4:02 PM |
| Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
finance.yahoo.com - January 19 at 11:46 PM |
| Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
finance.yahoo.com - January 19 at 4:36 PM |
| Do Options Traders Know Something About Sorrento (SRNE) Stock We Don't?
finance.yahoo.com - January 19 at 4:36 PM |
 | These Nasdaq Biotech Stocks Doubled in 2020. Here's Why They're Soaring on Friday
fool.com - January 16 at 9:37 AM |
| Sorrento Stock Could Hit $30, Says Analyst
finance.yahoo.com - January 15 at 3:28 AM |
| Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
finance.yahoo.com - January 10 at 6:15 PM |
| February 26th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - January 7 at 4:14 PM |
 | SRNE Feb 2021 8.500 call
uk.finance.yahoo.com - January 6 at 12:06 AM |
| Sorrento Therapeutics
fool.com - January 6 at 12:06 AM |
| Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
finance.yahoo.com - December 30 at 2:18 PM |
| SRNE Dec 2020 13.000 call
au.finance.yahoo.com - December 28 at 12:24 AM |
| SRNE Dec 2020 12.000 call
au.finance.yahoo.com - December 27 at 12:03 AM |
| Sorrento Pops 8% Pre-Market On FDA Application For Covid-19 Test
nasdaq.com - December 23 at 5:13 PM |
| Noteworthy Wednesday Option Activity: SPCE, SRNE, BA
nasdaq.com - December 23 at 5:13 PM |
| Sorrento Up on Request for Emergency Authorization for Covid Test
finance.yahoo.com - December 23 at 5:13 PM |
| The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
msn.com - December 23 at 12:12 PM |
| Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen
finance.yahoo.com - December 22 at 8:30 PM |
| Is SRNE A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:52 AM |
